KIT and acute myeloid leukemia: Benbarche and colleagues showed that in normal hematopoietic cells, as well as other AML subtypes, this particular region is inactive and KIT expression is driven by other enhancers, such as a previously identified classical 3′ enhancer [33] (Figure 4A).